In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Bio-Rad Labs gets hereditary hemochromatosis gene portfolio

Executive Summary

Bio-Rad Labs (manufactures/distributes life science research products, clinical diagnostics) will acquire Progenitor's (gene discovery) intellectual property relating to hereditary hemochromatosis (iron overload disease or "HH").
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
Deal Status
  • Final
Deal Type
  • Alliance
    • Product Purchase
    • Intra-Biotech Deal

Related Companies

Advertisement
UsernamePublicRestriction

Register